Paul Bisaro
CIK: 0001237253
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jul 15, 2026No ticker
Keenova Therapeutics plc
Award(A)DirectRestricted Stock Units
4.4K shares- - Jun 4, 2026MYGN
MYRIAD GENETICS INC
Award(A)Direct59.7K shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
Disposition(D)DirectRestricted Stock Units
2.2K shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
Tax Payment(F)Direct619 shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
Exercise(M)Direct2.7K shares- - May 14, 2026MYGN
MYRIAD GENETICS INC
Purchase(P)Direct7.5K shares at avg. $3.69$28K - May 13, 2026ZTS
Zoetis Inc.
Purchase(P)Direct2K shares at avg. $75.88$152K - Feb 23, 2026No ticker
Keenova Therapeutics plc
Award(A)DirectRestricted Stock Units
4K shares- - Feb 19, 2026ZTS
Zoetis Inc.
Exercise(M)Direct1.6K shares- - Feb 18, 2026ZTS
Zoetis Inc.
Award(A)DirectRestricted Stock Unit
1.9K shares- - Jan 1, 2026No ticker
Keenova Therapeutics plc
Disposition(D)DirectRestricted Stock Units
2.5K shares- - Jan 1, 2026No ticker
Keenova Therapeutics plc
Exercise(M)Direct3K shares- - Jan 1, 2026No ticker
Keenova Therapeutics plc
Tax Payment(F)Direct854 shares- - Aug 14, 2025No ticker
Mallinckrodt plc
Award(A)DirectRestricted Stock Units
4.1K shares- - Jul 31, 2025No ticker
Mallinckrodt plc
Award(A)DirectRestricted Stock Units
27.4K shares- - Jun 5, 2025MYGN
MYRIAD GENETICS INC
Award(A)Direct49.8K shares- - Feb 19, 2025ZTS
Zoetis Inc.
Award(A)DirectRestricted Stock Unit
1.6K shares- - Feb 8, 2025ZTS
Zoetis Inc.
Exercise(M)Direct1.2K shares- - Feb 6, 2025ZTS
Zoetis Inc.
Exercise(M)Direct1.2K shares- - Jan 1, 2025No ticker
Mallinckrodt plc
Disposition(D)DirectRestricted Stock Units
2.1K shares- - Jan 1, 2025No ticker
Mallinckrodt plc
Tax Payment(F)Direct489 shares- - Jan 1, 2025No ticker
Mallinckrodt plc
Exercise(M)Direct2.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  No ticker Keenova Therapeutics plc | Award(A) Restricted Stock Units | 4,406 | - | - | Direct |
| Jun 4, 2026 |  MYGN MYRIAD GENETICS INC | Award(A) | 59,701 | - | $0 | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Disposition(D) Restricted Stock Units | 2,197 | - | - | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Tax Payment(F) | 619 | - | $0 | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Exercise(M) | 2,685 | - | $0 | Direct |
| May 14, 2026 | MYGN MYRIAD GENETICS INC | Purchase(P) | 7,500 | $3.69 | $27,638 | Direct |
| May 13, 2026 |  ZTS Zoetis Inc. | Purchase(P) | 2,000 | $75.88 | $151,750 | Direct |
| Feb 23, 2026 | No ticker Keenova Therapeutics plc | Award(A) Restricted Stock Units | 3,984 | - | - | Direct |
| Feb 19, 2026 | ZTS Zoetis Inc. | Exercise(M) | 1,619 | - | $0 | Direct |
| Feb 18, 2026 | ZTS Zoetis Inc. | Award(A) Restricted Stock Unit | 1,936 | - | - | Direct |
| Jan 1, 2026 | No ticker Keenova Therapeutics plc | Disposition(D) Restricted Stock Units | 2,466 | - | - | Direct |
| Jan 1, 2026 | No ticker Keenova Therapeutics plc | Exercise(M) | 3,014 | - | $0 | Direct |
| Jan 1, 2026 | No ticker Keenova Therapeutics plc | Tax Payment(F) | 854 | - | $0 | Direct |
| Aug 14, 2025 | No ticker Mallinckrodt plc | Award(A) Restricted Stock Units | 4,062 | - | - | Direct |
| Jul 31, 2025 | No ticker Mallinckrodt plc | Award(A) Restricted Stock Units | 27,357 | - | - | Direct |
| Jun 5, 2025 | MYGN MYRIAD GENETICS INC | Award(A) | 49,796 | - | - | Direct |
| Feb 19, 2025 | ZTS Zoetis Inc. | Award(A) Restricted Stock Unit | 1,596 | - | - | Direct |
| Feb 8, 2025 | ZTS Zoetis Inc. | Exercise(M) | 1,225 | - | - | Direct |
| Feb 6, 2025 | ZTS Zoetis Inc. | Exercise(M) | 1,236 | - | - | Direct |
| Jan 1, 2025 | No ticker Mallinckrodt plc | Disposition(D) Restricted Stock Units | 2,052 | - | - | Direct |
| Jan 1, 2025 | No ticker Mallinckrodt plc | Tax Payment(F) | 489 | - | $0 | Direct |
| Jan 1, 2025 | No ticker Mallinckrodt plc | Exercise(M) | 2,507 | - | $0 | Direct |
1-22 of 22 transactions
About Bisaro Paul
Bisaro Paul (SEC CIK 0001237253) files insider reports with the SEC as Director of Keenova Therapeutics plc, Director of MYRIAD GENETICS INC (MYGN) and Director of Zoetis Inc. (ZTS).
Signal8 holds 16 ownership filings by Bisaro Paul, all Form 4s, filed between Jan 2, 2025 and Jul 17, 2026. Those filings report 22 transactions, from Jan 1, 2025 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bisaro Paul's filings is in BRIDGEWATER, NJ.
Recent filings by Bisaro Paul
- Jul 15, 2026: Grant or award of Keenova Therapeutics plc derivative securities (Form 4, code A).
- Jun 4, 2026: Grant or award of MYGN shares (Form 4, code A).
- Jun 2, 2026: Disposition to issuer transaction of Keenova Therapeutics plc derivative securities (Form 4, code D).
- Jun 2, 2026: Tax withholding of Keenova Therapeutics plc shares (Form 4, code F).
- Jun 2, 2026: Option exercise of Keenova Therapeutics plc shares (Form 4, code M).